ANESTHESIOLOGISTS do not need to be reminded of the devastating consequences of cigarette smoking. Our practices are affected on a near-daily basis—we often care for patients who require surgery for diseases caused by smoking, and we manage smoking-related perioperative morbidity such as respiratory complications. Usually, we successfully deal with these challenges and deliver these patients safely back to their families. However, the consequences of smoking do not end at the recovery room door. Surgeons have long maintained that the healing of surgical wounds is impaired in smokers, and most clinical and experimental studies confirm that smoking status is a risk factor for wound dehiscence and infections.1–6
Two important recent prospective studies show that preoperative abstinence from smoking can reduce the risk of wound-related complications. These studies, one in orthopedic surgery patients7
and one in volunteers,8
found dramatic reductions in the frequency of wound-related complications when smokers quit from 4 to 8 weeks before surgery. These studies did not address whether more brief periods of abstinence also reduce risk. In this issue of Anesthesiology, Kuri et al.9
attempt to answer this question.
Why is wound healing impaired in smokers? Clinical studies suggest that wounds requiring wide surgical undermining, such as facelifts, are particularly vulnerable.4,10,11
This implies that decreased tissue oxygenation, an important determinant of wound healing,12
may be a key factor. Smoking a cigarette decreases subcutaneous oxygen tension in humans,13
consistent with the ability of smoke constituents, such as nicotine and carbon monoxide, to produce peripheral vasoconstriction and to impair the capacity of hemoglobin to carry oxygen, respectively. However, many other factors could also contribute. Nicotine or other components of cigarette smoke could directly affect the function of cells such as fibroblasts and immune cells important to healing,14,15
although recent evidence suggests that the topical application of nicotine to wounds may in fact stimulate angiogenesis and accelerate wound healing.16
Microvascular disease caused by smoking may also interfere with angiogenesis via
impaired release of mediators such as nitric oxide that are important for wound repair.17,18
To the extent that impaired wound healing is caused by the acute pharmacologic effects of smoke constituents, even relatively brief periods of abstinence should be beneficial. For example, concentrations of nicotine and carboxyhemoglobin decrease dramatically within 12 h after the last cigarette.19
If changes in immune function or endothelial function are involved, a longer period may be required for full benefit. Studies attempting to determine how the duration of abstinence affects perioperative risk are inherently difficult, given that it is almost impossible to implement the optimal study design of randomly assigning patients to different durations of abstinence from cigarettes. Rather, studies depend on spontaneous changes in smoking behavior to obtain varying abstinence durations. This raises the possibility of selection bias. Smokers with more severe disease or those undergoing more extensive medical procedures are more likely to quit smoking.20,21
Therefore, characteristics of patients who are able to quit within a few weeks of surgery may differ in important ways from those who continue to smoke.
Accepting this limitation, Kuri et al.
examined a patient population with both a high prevalence of smoking and a high rate of wound-related complications—patients requiring resection of head and neck cancers, followed by free flap reconstruction. Although a retrospective study, with the problems inherent in such a design, determination of smoking history and ascertainment of wound-related complications were appropriately conservative, and other patient characteristics were nicely matched. “Smokers” were defined as those patients who had smoked within a week. Because no information is given regarding how many of these patients had quit before hospital admission, the effects of brief periods of abstinence (< 1 week) could not be evaluated. In multivariate analysis, odds ratios for patients reporting at least 1 week of preoperative abstinence indicated at least a threefold decrease in risk for wound-related complications (defined as an event requiring surgical intervention postoperatively) for all grouping of durations, although this was not statistically significant for those reporting 1–3 weeks of abstinence. This lack of significance is the basis of the authors’ conclusion that 3 weeks of abstinence is required for benefit, but is more likely a function of relatively small numbers of patients studied. Presentation of the frequency of impaired wound healing as a function of a 3-week moving time average suggested that risk declined steadily over approximately the first 6 weeks of abstinence, although this analysis permits no statistical conclusions and itself demonstrates considerable variability (e.g.
, the sudden appearance of a high frequency of complications at 7–10 weeks of abstinence). What seems clear is that the longer the duration of abstinence the better, as supported by a separate analysis showing a significant correlation between the duration of abstinence and wound-related complications. The inability to define a clear threshold for the duration of abstinence that confers benefit mirrors studies that examine the influence of preoperative abstinence duration on pulmonary risk. These studies also could only conclude that “longer is better,”22–25
suggesting that several months of abstinence is necessary for full benefit.
Although the data of Kuri et al.
do not provide definitive answers to the question of how long is long enough to significantly reduce the risk of wound-related complications, their study is a valuable addition to the body of evidence suggesting that preoperative smoking cessation can improve perioperative outcomes. However, the most important question may not be the optimal duration of preoperative abstinence but whether smokers can maintain long-term abstinence after surgery, because even if preoperative abstinence had no effect on perioperative outcomes, we should still help our surgical patients quit smoking. Increasing evidence suggests that surgery represents a golden opportunity for smokers to quit, with great benefit to their health.26–28
For example, even in the absence of any interventions by medical personnel, the rate of spontaneous quitting is increased in surgical patients compared with the general population of smokers, especially in those undergoing more extensive procedures.28
Effective tobacco interventions, modeled on those currently available in ambulatory settings, could take advantage of this natural tendency and further increase quit rates. Surgery could thus serve as a “teachable moment” to promote prolonged abstinence, if only we will take the time to teach.29
A recent survey suggests that surgeons and anesthesiologists are not consistently doing so.26
This is not surprising, because few surgical specialists are familiar with the dramatic advances that have occurred during the past 20 yr in the treatment of tobacco dependence.30
There are now methods of proven efficacy that can at least double the chances that smokers will quit.30
Optimal application of these techniques to the surgical setting will require answers to several questions. How can surgeons and anesthesiologists best incorporate tobacco interventions into their busy practices? How can surgical patients effectively access other resources such as “quitlines” and nicotine treatment specialists? Is it safe to use nicotine replacement therapy in surgical patients? In the meantime, simply asking about tobacco use and providing strong, personalized, and consistent advice that patients abstain for as long as possible before and after surgery are steps that anesthesiologists can take now to help their patients deal with tobacco dependence—if we accept that it is our responsibility to do so.
David O. Warner, M.D.,
Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota. email@example.com
1. Chang LD, Buncke G, Slezak S, Buncke HJ: Cigarette smoking, plastic surgery, and microsurgery. J Reconstr Microsurg 1996; 12:467–74
2. Fawcett A, Shembekar M, Church JS, Vashisht R, Springall RG, Nott DM: Smoking, hypertension, and colonic anastomotic healing: A combined clinical and histopathological study. Gut 1996; 38:714–8
3. Myles PS, Iacono GA, Hunt JO, Fletcher H, Morris J, McIlroy D, Fritschi L: Risk of respiratory complications and wound infection in patients undergoing ambulatory surgery: Smokers versus nonsmokers. Anesthesiology 2002; 97:842–7
4. Silverstein P: Smoking and wound healing. Am J Med 1992; 93:22S–4S
5. Nolan J, Jenkins RA, Kurihara K, Schultz RC: The acute effects of cigarette smoke exposure on experimental skin flaps. Plast Reconstr Surg 1985; 75:544–51
6. Sorensen LT, Horby J, Friis E, Pilsgaard B, Jorgensen T: Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol 2002; 28:815–20
7. Moller AM, Villebro N, Pedersen T, Tonnesen H: Effect of preoperative smoking intervention on postoperative complications: A randomised clinical trial. Lancet 2002; 359:114–7
8. Sorensen LT, Karlsmark T, Gottrup F: Abstinence from smoking reduces incisional wound infection: A randomized controlled trial. Ann Surg 2003; 238:1–5
9. Kuri M, Nakagawa M, Tanaka H, Hasuo S, Kishi Y: Determination of the duration of preoperative smoking cessation to improve wound healing after head and neck surgery. Anesthesiology 2005; 102:892–6
10. Rees TD, Liverett DM, Guy CL: The effect of cigarette smoking on skin-flap survival in the face lift patient. Plast Reconstr Surg 1984; 73:911–5
11. Riefkohl R, Wolfe JA, Cox EB, McCarty KS Jr: Association between cutaneous occlusive vascular disease, cigarette smoking, and skin slough after rhytidectomy. Plast Reconstr Surg 1986; 77:592–5
12. Hopf HW, Hunt TK, West JM, Blomquist P, Goodson WH III, Jensen JA, Jonsson K, Paty PB, Rabkin JM, Upton RA, von Smitten K, Whitney JD: Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg 1997; 132:997–1004
13. Jensen JA, Goodson WH, Hopf HW, Hunt TK: Cigarette smoking decreases tissue oxygen. Arch Surg 1991; 126:1131–4
14. Wong LS, Green HM, Feugate JE, Yadav M, Nothnagel EA, Martins-Green M: Effects of “second-hand” smoke on structure and function of fibroblasts, cells that are critical for tissue repair and remodeling. BMC Cell Biol 2004; 5:13
15. Tomek RJ, Rimar S, Eghbali-Webb M: Nicotine regulates collagen gene expression, collagenase activity, and DNA synthesis in cultured cardiac fibroblasts. Mol Cell Biochem 1994; 136:97–103
16. Jacobi J, Jang JJ, Sundram U, Dayoub H, Fajardo LF, Cooke JP: Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Path 2002; 161:97–104
17. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE: Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88:2149–55
18. Neunteufl T, Heher S, Kostner K, Mitulovic G, Lehr S, Khoschsorur G, Schmid RW, Maurer G, Stefenelli T: Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol 2002; 39:251–6
19. Egan TD, Wong KC: Perioperative smoking cessation and anesthesia: A review. J Clin Anesth 1992; 4:63–72
20. Crouse JRD, Hagaman AP: Smoking cessation in relation to cardiac procedures. Am J Epidemiol 1991; 134:699–703
21. France EK, Glasgow RE, Marcus AC: Smoking cessation interventions among hospitalized patients: What have we learned? Prev Med 2001; 32:376–88
22. Bluman LG, Mosca L, Newman N, Simon DG: Preoperative smoking habits and postoperative pulmonary complications. Chest 1998; 113:883–9
23. Warner MA, Divertie MB, Tinker JH: Preoperative cessation of smoking and pulmonary complications in coronary artery bypass patients. Anesthesiology 1984; 60:380–3
24. Warner MA, Offord KP, Warner ME, Lennon RL, Conover MA, Jansson-Schumacher U: Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: A blinded prospective study of coronary artery bypass patients. Mayo Clin Proc 1989; 64:609–16
25. Nakagawa M, Tanaka H, Tsukuma H, Kishi Y: Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest 2001; 120:705–10
26. Warner DO, Sarr MG, Offord K, Dale LC: Anesthesiologists, general surgeons, and tobacco interventions in the perioperative period. Anesth Analg 2004; 99:1776–83
27. Warner DO: Preoperative smoking cessation: The role of the primary care provider. Mayo Clin Proc 2005; 80:252–8
28. Warner DO, Patten CA, Ames SC, Offord K, Schroeder D: Smoking behavior and perceived stress in cigarette smokers undergoing elective surgery. Anesthesiology 2004; 100:1125–37
29. McBride CM, Emmons KM, Lipkus IM: Understanding the potential of teachable moments: The case of smoking cessation. Health Ed Res 2003; 18:156–70
30. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service Report. JAMA 2000; 283:3244–54
© 2005 American Society of Anesthesiologists, Inc.